Skip to content

Clinical trials

Observational Adenocarcinoma of Lung trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma of Lung Phase: Observational Country / region: United States Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20111
20123
20142
20161
20191
20211
20223
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting3
Terminated2
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology4
Mayo Clinic2
University of Colorado, Denver2
Alaunos Therapeutics1
Dana-Farber Cancer Institute1
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano1
H. Lee Moffitt Cancer Center and Research Institute1
Myriad Genetic Laboratories, Inc.1
Pathway Genomics1
SpeciCare1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma of Lung15
Lung Neoplasms9
Carcinoma, Non-Small-Cell Lung8
Pancreatic Neoplasms3
Cholangiocarcinoma2
Colonic Neoplasms2
Colorectal Neoplasms2
Esophageal Neoplasms2
Liver Neoplasms2
Neoplasm Metastasis2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.